Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06890663 · ClinicalTrials.gov registry record · NA
Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health
A NA study, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT06890663 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 11 participants.
The verdict
NCT06890663, a NA study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.
Interventions
- OTHER Nonspecific Hypnotherapy for Relaxation
- OTHER Gut-Directed Hypnotherapy (GDH)
- OTHER 3-month Follow-Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06890663
The ClinicalTrials.gov registry entry for NCT06890663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nonspecific Hypnotherapy for Relaxation is the first listed.
NCT06890663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06890663 about?
NCT06890663 is a clinical study titled "Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health". This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.
What is the current status of trial NCT06890663?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2025-03-19. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT06890663?
The interventions under investigation include: Nonspecific Hypnotherapy for Relaxation (OTHER), Gut-Directed Hypnotherapy (GDH) (OTHER), 3-month Follow-Up (OTHER).
Who is sponsoring clinical trial NCT06890663?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.